Vital KSK Holdings, Inc. (3151) AI Stock Analysis

Vital KSK Holdings, Inc.

(TSE/TYO:3151)

Select Model

Rating:78Outperform

Price Target:JPY 1,840.00▲(19.09% Upside)

Action:reiterated

Date:08/17/26

Strong balance sheet and improving profitability drive solid financial performance, supported by positive technical uptrend and attractive valuation; cash flow volatility presents a key risk, but low leverage and dividend yield enhance appeal in the medical distribution sector.

Positive Factors

Low and improving leverageA declining debt burden and low leverage strengthen financial resilience, reduce interest and refinancing risk, and give the distribution business greater flexibility to fund operations through varying market and working-capital conditions.

Negative Factors

Volatile cash generationLarge swings in operating and free cash flow indicate inconsistent conversion of accounting earnings into cash, likely linked to working capital or timing. This can constrain reinvestment, dividends, and balance-sheet flexibility despite reported profitability.

Vital KSK Holdings, Inc. (3151) vs. iShares MSCI Japan ETF (EWJ)

Market Cap: JPY 74.22B
Dividend Yield: 4.60%
Average Volume (3M): 89.09K
Price to Earnings (P/E): 10.6
Beta (1Y): 0.37
Revenue Growth: 2.43%
EPS Growth: 1.19%
Country: Japan
Employees: 3,871
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Distribution

Vital KSK Holdings, Inc. Business Overview & Revenue Model

Company Description

Vital KSK Holdings, Inc. is a Japanese entity primarily involved in the wholesale distribution of pharmaceutical products. Its diverse wholesale operations also cover veterinary medications, agricultural chemicals and supplies, and various types of m...

Vital KSK Holdings, Inc. Financial Statement Overview

Summary

Based on income statement (78) showing steady revenue and net income growth with modest margins, balance sheet (85) reflecting strong equity and reduced debt for stability, and cash flow (62) indicating volatility with periods of negative flows, overall financial performance is solid but tempered by cash inconsistencies.

Income Statement

78Positive

Balance Sheet

85Very Positive

Cash Flow

62Positive

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	616.92B	610.50B	600.37B	587.48B	579.77B	577.25B
Gross Profit	50.24B	49.58B	49.22B	48.30B	44.96B	43.98B
EBITDA	13.46B	8.08B	14.56B	12.16B	11.56B	10.87B
Net Income	7.03B	7.36B	7.31B	5.84B	4.83B	4.77B
Balance Sheet
Total Assets	322.29B	320.57B	299.43B	317.26B	297.32B	313.03B
Cash, Cash Equivalents and Short-Term Investments	22.76B	22.95B	23.10B	34.71B	19.03B	26.97B
Total Debt	5.57B	6.78B	7.70B	10.15B	10.87B	12.59B
Total Liabilities	206.37B	201.86B	192.12B	211.31B	197.15B	212.99B
Stockholders Equity	114.41B	117.22B	105.91B	104.66B	98.99B	98.96B
Cash Flow
Free Cash Flow	0	1.11B	-10.59B	18.47B	-9.60B	3.35B
Operating Cash Flow	0	4.83B	-8.02B	23.57B	-3.00B	7.49B
Investing Cash Flow	0	-1.07B	3.52B	-1.82B	-1.04B	-2.01B
Financing Cash Flow	0	-4.40B	-6.54B	-5.77B	-4.08B	-8.49B

Vital KSK Holdings, Inc. Technical Analysis

Technical Analysis SentimentPositive

Last Price1545.00

Price Trends

50DMA1566.41Negative

100DMA1556.93Negative

200DMA1480.95Positive

Market Momentum

MACD-4.62Negative

RSI50.04Neutral

STOCH18.84Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3151, the sentiment is Positive. The current price of 1545.00 is above the 20-day moving average (MA) of 1529.65, below the 50-day MA of 1566.41, and above the 200-day MA of 1480.95, indicating a neutral trend. The MACD of -4.62 indicates Negative momentum. The RSI at 50.04 is Neutral, neither overbought nor oversold. The STOCH value of 18.84 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3151.

Vital KSK Holdings, Inc. Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

JP:3151 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JP:3151	78Outperform	JPY 69.52B	10.63	―	4.60%	2.43%	1.19%
JP:6062	70Outperform	JPY 44.61B	11.04	―	3.14%	5.16%	37.79%
JP:7071	64Neutral	JPY 38.05B	12.02	―	1.03%	6.17%	-33.01%
JP:2689	62Neutral	JPY 20.14B	10.23	―	4.17%	2.20%	-31.67%
JP:3417	52Neutral	JPY 13.41B	17.70	―	3.09%	2.87%	-73.55%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
JP:9265	49Neutral	JPY 8.87B	15.77	―	3.08%	-0.41%	2.32%

* Healthcare Sector Average

Performance Comparison

JP:3151 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
JP:3151	Vital KSK Holdings, Inc.	1545.00	357.58	30.11%
JP:2689	OLBA HEALTHCARE HOLDINGS, Inc.	1920.00	-43.61	-2.22%
JP:3417	Ohki Health Care Holdings, Inc.	972.00	-403.75	-29.35%
JP:6062	Charm Care Corporation	1368.00	313.27	29.70%
JP:7071	Amvis Holdings.Inc.	387.00	-131.71	-25.39%
JP:9265	YAMASHITA HEALTH CARE HOLDINGS, INC.	3475.00	351.86	11.27%

Vital KSK Holdings, Inc. Corporate Events

Vital KSK Holdings Posts Higher Sales but Sharp Profit Drop in First Quarter

Aug 6, 2026

Vital KSK Holdings reported first-quarter consolidated net sales of ¥154.6 billion, up 4.3% year on year, but saw declines in profitability, with core operating profit down 6.4% and profit attributable to owners of parent falling 48.2% to ¥...

Vital KSK Holdings Continues Share Buyback Under Multi-Billion Yen Authorization

Aug 3, 2026

Vital KSK Holdings, Inc. has reported the execution of a share repurchase program, buying back 241,500 common shares for a total of ¥386.7 million between July 1 and July 31, 2026 through market purchases under discretionary investment managemen...

Vital KSK Holdings to Book ¥8.1 Billion Extraordinary Gain on Share Sales

Jul 27, 2026

Vital KSK Holdings, Inc., a TSE Prime Market-listed company based in Tokyo, operates through consolidated subsidiaries that hold listed investment securities as part of its broader asset management activities. The group is currently reviewing cross-s...

Vital KSK Completes Treasury Share Disposal for Performance-Linked Stock Plan

Jul 24, 2026

Vital KSK Holdings has completed the payment procedures for the disposal of its treasury shares used as performance-linked restricted stock compensation, following a resolution by its board of directors in late June 2026. This move reflects the compa...

Vital KSK Holdings Details Progress of Share Buyback Program

Jul 1, 2026

Vital KSK Holdings, Inc. has disclosed the status of its ongoing share repurchase program, conducted under provisions of Japan’s Companies Act and authorized by its board. The company is buying back common shares through market purchases, refle...

Vital KSK to Dispose of Treasury Shares for Performance-Linked Restricted Stock Plan

Jun 25, 2026

Vital KSK Holdings, Inc. has approved the disposal of 34,618 shares of its treasury stock as part of a performance-linked restricted stock compensation plan for a wide range of group personnel. The shares, valued at a total of ¥53.69 million at...

Vital KSK Begins Share Buyback Under ¥4 Billion Authorization

Jun 1, 2026

Vital KSK Holdings has disclosed the status of its ongoing share repurchase program, executing buybacks of 118,300 common shares for a total of ¥182.76 million between May 15 and May 31, 2026, via market purchases under discretionary investment...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026

Vital KSK Holdings, Inc. AI Stock Analysis